Gaucher's disease: Difference between revisions
No edit summary |
No edit summary |
||
(9 intermediate revisions by 2 users not shown) | |||
Line 4: | Line 4: | ||
| Image = Gaucher's disease H shaped vertebral bodies 001.jpg | | Image = Gaucher's disease H shaped vertebral bodies 001.jpg | ||
| Caption = MRI: H-shaped vertebral bodies in a patient with Gaucher's disease. <br> (Image courtesy of RadsWiki) | | Caption = MRI: H-shaped vertebral bodies in a patient with Gaucher's disease. <br> (Image courtesy of RadsWiki) | ||
}} | }} | ||
{{Gaucher's disease}} | {{Gaucher's disease}} | ||
Line 20: | Line 9: | ||
'''For patient information [[Gaucher's disease (patient information)|click here]]''' | '''For patient information [[Gaucher's disease (patient information)|click here]]''' | ||
{{CMG}}; | {{CMG}}; {{AE}} {{CZ}} | ||
'''Synonyms and related keywords:''' Cerebroside lipidosis syndrome, Gauchers disease, Gaucher splenomegaly, Gaucher syndrome, GD, Glucocerebrosidase deficiency, Glucocerebrosidosis, Glucosylceramidase deficiency, Glucosylceramide beta-glucosidase deficiency, Glucosylceramide lipidosis, Glucosyl cerebroside lipidosis, Kerasin histiocytosis, Kerasin lipoidosis, Kerasin thesaurismosis, Lipoid histiocytosis (kerasin type) | '''Synonyms and related keywords:''' Cerebroside lipidosis syndrome, Gauchers disease, Gaucher splenomegaly, Gaucher syndrome, GD, Glucocerebrosidase deficiency, Glucocerebrosidosis, Glucosylceramidase deficiency, Glucosylceramide beta-glucosidase deficiency, Glucosylceramide lipidosis, Glucosyl cerebroside lipidosis, Kerasin histiocytosis, Kerasin lipoidosis, Kerasin thesaurismosis, Lipoid histiocytosis (kerasin type) | ||
==[[Gaucher's disease overview|Overview]]== | ==[[Gaucher's disease overview|Overview]]== | ||
==[[Gaucher's disease historical perspective|Historical Perspective]]== | |||
==[[Gaucher's disease classification|Classification]]== | |||
==[[Gaucher's disease pathophysiology|Pathophysiology]]== | ==[[Gaucher's disease pathophysiology|Pathophysiology]]== | ||
==[[Gaucher's disease differential diagnosis|Differentiating Gaucher's disease from other Diseases]]== | |||
==[[Gaucher's disease epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Gaucher's disease epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Gaucher's disease risk factors|Risk Factors]]== | ==[[Gaucher's disease risk factors|Risk Factors]]== | ||
==[[Gaucher's disease screening|Screening]]== | |||
==[[Gaucher's disease natural history|Natural History, Complications and Prognosis]]== | ==[[Gaucher's disease natural history|Natural History, Complications and Prognosis]]== | ||
Line 36: | Line 33: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Gaucher's disease history and symptoms|History and Symptoms ]] | [[ Gaucher's disease physical examination|Physical Examination]] | [[Gaucher's disease laboratory findings|Laboratory Findings]] | [[Gaucher's disease CT|CT | [[Gaucher's disease history and symptoms|History and Symptoms ]] | [[ Gaucher's disease physical examination|Physical Examination]] | [[Gaucher's disease laboratory findings|Laboratory Findings]] | [[Gaucher's disease chest x ray|Chest X Ray]] | [[Gaucher's disease CT|CT]] | [[Gaucher's disease MRI|MRI]] | [[Gaucher's disease ultrasound|Ultrasound]] | [[Gaucher's disease other imaging findings|Other Imaging Findings]] | [[Gaucher's disease other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Gaucher's disease medical therapy|Medical Therapy]] | [[Gaucher's disease surgery |Surgery]] | [[Gaucher's disease primary prevention|Primary Prevention]] | [[Gaucher's disease secondary prevention|Secondary Prevention]] | [[Gaucher's disease future or investigational therapies|Future or Investigational Therapies]] | [[Gaucher's disease medical therapy|Medical Therapy]] | [[Gaucher's disease surgery |Surgery]] | [[Gaucher's disease primary prevention|Primary Prevention]] | [[Gaucher's disease secondary prevention|Secondary Prevention]] | [[Gaucher's disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Gaucher's disease future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Gaucher's Disease case study one|Case #1]] | |||
Line 58: | Line 55: | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
Latest revision as of 18:50, 18 July 2016
Gaucher's disease | |
MRI: H-shaped vertebral bodies in a patient with Gaucher's disease. (Image courtesy of RadsWiki) |
Gaucher's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Gaucher's disease On the Web |
American Roentgen Ray Society Images of Gaucher's disease |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Synonyms and related keywords: Cerebroside lipidosis syndrome, Gauchers disease, Gaucher splenomegaly, Gaucher syndrome, GD, Glucocerebrosidase deficiency, Glucocerebrosidosis, Glucosylceramidase deficiency, Glucosylceramide beta-glucosidase deficiency, Glucosylceramide lipidosis, Glucosyl cerebroside lipidosis, Kerasin histiocytosis, Kerasin lipoidosis, Kerasin thesaurismosis, Lipoid histiocytosis (kerasin type)
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Gaucher's disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Template:Endocrine, nutritional and metabolic pathology